Physician profile
Shawn E Kidder
NPI 1831151869
$1,714.74
in general payments reported to CMS, 2019-2025
24 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.38 · 2020: $12.18 · 2021: $51.05 · 2022: $467 · 2023: $332 · 2024: $382 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $223.40 | 2022-2025 | Rexulti |
| Amgen INC. | $197.66 | 2022-2025 | Otezla, Repatha, Repatha |
| Abbvie INC. | $163.73 | 2022-2025 | |
| Novo Nordisk INC | $128.18 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $122.68 | 2023-2025 | Freestyle Libre 3, Cardiomems, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $115.57 | 2021-2024 | Airsupra |
| Lilly USA, LLC | $94.21 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $87.47 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $87.17 | 2022 | |
| Axsome Therapeutics, INC. | $82.63 | 2023-2024 | Sunosi, Auvelity |
| Janssen Pharmaceuticals, INC | $69.45 | 2019-2025 | Spravato |
| Lundbeck LLC | $66.27 | 2023-2025 | Rexulti |
| Inspire Medical Systems, INC. | $50.79 | 2024-2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $33.89 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.97 | 2023-2024 | Xifaxan |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $29.41 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $20.96 | 2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $19.84 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.62 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.11 | 2022 | |
| Dexcom, INC. | $15.49 | 2023 | Dexcom G6 Transmitter |
| Halozyme INC | $13.16 | 2023 | |
| Allergan, INC. | $12.18 | 2020 | |
| Eisai INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Kidder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.